Possible scenario
Incumbents Move Fast
20% Chance
Nolla's pilot validates consumer demand, but larger telehealth and pharmacy platforms respond quickly. Competition compresses Nolla's first-mover advantage while accelerating adoption of AI-assisted dermatology workflows across the sector.
Secondary impacts
- Healthcare +1.0%
- Technology +0.3%
- Consumer Cyclicals +0.1%
Tickers
- HIMS+2.9%
- GDRX+1.4%
- CVS+0.5%
Portfolio impact
S&P 500+0.2%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.